Immune checkpoint therapy has revolutionized cancer treatment, and antibodies targeting PD‐1, PD‐L1, and CTLA‐4 are successfully used to combat a wide variety of cancers.1, 2, 3, 4, 5, 6, 7, 8. The gene discussed is PDCD1; the disease is cancer.